Evidence map›Paper›PMID 28045510›Full record

ArticleBiochemistry2017

Anaerobic Heme Degradation: ChuY Is an Anaerobilin Reductase That Exhibits Kinetic Cooperativity.

Joseph W LaMattina, Michael Delrossi, Katherine G Uy, Nicholas D Keul, David B Nix, Anudeep R Neelam, William N Lanzilotta

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Biochemical and functional characterization ofFrontiers in microbiology · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Elucidating the origins of phycocyanobilin biosynthesis and phycobiliproteins.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Innovation and tinkering in the evolution of oxidases.Protein science : a publication of the Protein Society · 2022
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. HutW fromBiochemistry · 2021
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Joseph W LaMattinaDepartment of Biochemistry and Molecular Biology and ‡The Complex Carbohydrate Research Center, University of Georgia , Athens, Georgia 30602, United States.
Michael DelrossiDepartment of Biochemistry and Molecular Biology and ‡The Complex Carbohydrate Research Center, University of Georgia , Athens, Georgia 30602, United States.
Katherine G UyDepartment of Biochemistry and Molecular Biology and ‡The Complex Carbohydrate Research Center, University of Georgia , Athens, Georgia 30602, United States.
Nicholas D KeulDepartment of Biochemistry and Molecular Biology and ‡The Complex Carbohydrate Research Center, University of Georgia , Athens, Georgia 30602, United States.
David B NixDepartment of Biochemistry and Molecular Biology and ‡The Complex Carbohydrate Research Center, University of Georgia , Athens, Georgia 30602, United States.
Anudeep R NeelamDepartment of Biochemistry and Molecular Biology and ‡The Complex Carbohydrate Research Center, University of Georgia , Athens, Georgia 30602, United States.
William N LanzilottaDepartment of Biochemistry and Molecular Biology and ‡The Complex Carbohydrate Research Center, University of Georgia , Athens, Georgia 30602, United States.ORCID 0000-0002-4852-321X
University of Georgia · US

Funding

TR&D1: Stem Cell and Induced Pluripotent Stem Cell Resources (Pages 116-134)P41GM103490 · NIGMS · UNIVERSITY OF GEORGIA · PI PIERCE, J. MICHAEL · 2012 to 2018
$13.7M
A radical new paradigm for heme degradation in enteric pathogensR01GM124203 · NIGMS · UNIVERSITY OF GEORGIA · PI LANZILOTTA, WILLIAM N · 2017 to 2020
$1.3M
NIGMS NIH HHS P41 GM103490NIGMS NIH HHS R01 GM124203
6 · The paper itself

Abstract

Heme catabolism is an important biochemical process that many bacterial pathogens utilize to acquire iron. However, tetrapyrrole catabolites can be reactive and often require further processing for transport out of the cell or conversion to another useful cofactor. In previous work, we presented in vitro evidence of an anaerobic heme degradation pathway in Escherichia coli O157:H7. Consistent with reactions that have been reported for other radical S-adenosyl-l-methionine methyltransferases, ChuW transfers a methyl group to heme by a radical-mediated mechanism and catalyzes the β-scission of the porphyrin macrocycle. This facilitates iron release and the production of a new linear tetrapyrrole termed "anaerobilin". In this work, we describe the structure and function of ChuY, an enzyme expressed downstream from chuW within the same heme utilization operon. ChuY is structurally similar to biliverdin reductase and forms a dimeric complex in solution that reduces anaerobilin to the product we have termed anaerorubin. Steady state analysis of ChuY exhibits kinetic cooperativity that is best explained by a random addition mechanism with a kinetically preferred path for initial reduced nicotinamide adenine dinucleotide phosphate binding.

Indexed as

Models, MolecularApoenzymesBiocatalysisDeuteriumDimerizationEscherichia coli O157Escherichia coli ProteinsHemeHydrolysisMolecular StructureMolecular WeightNADPOxidation-ReductionOxidoreductases Acting on CH-CH Group DonorsProtein ConformationProtein Interaction Domains and MotifsanaerobilinanaerorubinApoenzymesbiliverdin reductaseChuY protein, E coliDeuteriumEscherichia coli ProteinsHemeNADPOxidoreductases Acting on CH-CH Group DonorsRecombinant ProteinsTetrapyrroles

Identifiers

PMID28045510
PMCPMC7210504
OpenAlexW2561806674

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.